CG ONCOLOGY INC (CGON) Stock Balance Sheet
NASDAQ:CGON - Nasdaq - US1569441009 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 41.47M | 257.07M | 8.27M | 88.14M | 53.61M | |||
| Marketable Securities | 646.96M | 484.93M | 179.41M | 55.34M | 0.00 | |||
| Receivables | 345.00K | 781.00K | 92.00K | 303.00K | 2.00K | |||
| Other Current Assets | 12.41M | 11.43M | 6.36M | 3.42M | 4.80M | |||
| Total Current Assets | 701.19M | 754.21M | 194.12M | 147.21M | 58.41M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.30M | 493.00K | 491.00K | 506.00K | 200.00K | |||
| Other Non-Current Assets | 516.00K | 94.00K | 4.69M | 33.00K | 85.00K | |||
| Total Non-Current Assets | 26.99M | 587.00K | 5.18M | 539.00K | 285.00K | |||
| TOTAL ASSETS | 728.18M | 754.80M | 199.30M | 147.75M | 58.69M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 352.00K | 8.97M | 2.94M | |||
| Accrued Expenses | 15.43M | 14.41M | 9.54M | 5.30M | 1.96M | |||
| Accounts Payable | 6.73M | 6.52M | 3.24M | 985.00K | 1.00M | |||
| Other Current Liabilities | 481.00K | 436.00K | 1.12M | 173.00K | 68.00K | |||
| Total Current Liabilities | 22.64M | 21.37M | 14.25M | 15.43M | 5.97M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 13.00K | 6.88M | 12.41M | |||
| Other Non-Current Liabilities | 781.00K | 52.00K | 244.00K | 257.00K | 50.00K | |||
| Total Non-Current Liabilities | 781.00K | 52.00K | 257.00K | 7.14M | 12.46M | |||
| TOTAL LIABILITIES | 23.42M | 21.42M | 14.51M | 22.57M | 18.44M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -252.43M | -217.98M | -129.94M | -81.33M | -45.89M | |||
| Additional Paid In Capital | 957.18M | 951.35M | 6.84M | 3.64M | 3.27M | |||
| Common Shares | 8.00K | 8.00K | 307.89M | 202.87M | 82.87M | |||
| Shares Outstanding | 76.22M | 76.15M | 63.48M | 63.48M | 63.48M | |||
| Tangible Book Value per Share | 9.25 | 9.63 | -1.94 | -1.22 | -0.67 | |||
| Total Shareholders' Equity | 704.76M | 733.38M | 184.79M | 125.18M | 40.25M | |||
| TOTAL LIABILITIES AND EQUITY | 728.18M | 754.80M | 199.30M | 147.75M | 58.69M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.00 | 0.05 | 0.31 | |||
| Current Ratio | 30.97 | 35.30 | 13.62 | 9.54 | 9.78 | |||
| Return On Assets (ROA) | -14.50% | -11.66% | -34.02% | -29.64% | -31.32% | |||
| Return On Equity (ROE) | -14.98% | -12.00% | -36.69% | -34.98% | -45.67% | |||
All data in USD , ROIC based on taxRate of 0.21